Process View
The acquisition, loss or modification of a protein or lipid within a triglyceride-rich lipoprotein particle, including the hydrolysis of triglyceride by lipoprotein lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride from a triglyceride-rich lipoprotein particle.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "triglyceride rich lipoprotein particle remodeling"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
Apoa1 | apolipoprotein A-I | 0.841 | Human Mouse | |
F12 | coagulation factor XII (Hageman factor) | 0.294 | ||
Nos3 | nitric oxide synthase 3, endothelial cell | 0.178 | ||
Apoc4 | apolipoprotein C-IV | 0.173 | ||
Hpd | 4-hydroxyphenylpyruvic acid dioxygenase | 0.148 | ||
Ambp | alpha 1 microglobulin/bikunin | 0.135 | ||
Lyz2 | lysozyme 2 | 0.131 | ||
Cyp2d26 | cytochrome P450, family 2, subfamily d, polypeptide 26 | 0.129 | ||
Ldlr | low density lipoprotein receptor | 0.116 | ||
Apob | apolipoprotein B | 0.112 | ||
Gcgr | glucagon receptor | 0.112 | ||
F2 | coagulation factor II | 0.106 | ||
Lepr | leptin receptor | 0.104 | ||
Ahsg | alpha-2-HS-glycoprotein | 0.104 | ||
Prodh2 | proline dehydrogenase (oxidase) 2 | 0.083 | ||
Plg | plasminogen | 0.070 | ||
Pparg | peroxisome proliferator activated receptor gamma | 0.064 | ||
Abca1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.061 | ||
Agt | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.058 | ||
Apom | apolipoprotein M | 0.057 | ||
Apoa2 | apolipoprotein A-II | 0.052 | ||
Cyp2d10 | cytochrome P450, family 2, subfamily d, polypeptide 10 | 0.049 | ||
Mt1 | metallothionein 1 | 0.045 | ||
Scd1 | stearoyl-Coenzyme A desaturase 1 | 0.045 | ||
Asgr2 | asialoglycoprotein receptor 2 | 0.043 | ||
Serpinf2 | serine (or cysteine) peptidase inhibitor, clade F, member 2 | 0.038 | ||
Serpinc1 | serine (or cysteine) peptidase inhibitor, clade C (antithrombin), member 1 | 0.038 | ||
Fgg | fibrinogen gamma chain | 0.037 | ||
Fas | Fas (TNF receptor superfamily member 6) | 0.035 | ||
Slc27a5 | solute carrier family 27 (fatty acid transporter), member 5 | 0.034 | ||
Hgd | homogentisate 1, 2-dioxygenase | 0.033 | ||
Npc1 | Niemann Pick type C1 | 0.031 | ||
Aldob | aldolase B, fructose-bisphosphate | 0.030 | ||
Hnf4a | hepatic nuclear factor 4, alpha | 0.030 | ||
Rdh7 | retinol dehydrogenase 7 | 0.030 | ||
Lrp1 | low density lipoprotein receptor-related protein 1 | 0.029 | ||
Pzp | pregnancy zone protein | 0.027 | ||
Cebpa | CCAAT/enhancer binding protein (C/EBP), alpha | 0.027 | ||
Pten | phosphatase and tensin homolog | 0.025 | ||
Fgb | fibrinogen beta chain | 0.024 | ||
Apoc3 | apolipoprotein C-III | 0.023 | ||
Dmgdh | dimethylglycine dehydrogenase precursor | 0.023 | ||
Mbl2 | mannose-binding lectin (protein C) 2 | 0.021 | ||
Proc | protein C | 0.019 | ||
Gc | group specific component | 0.019 | ||
Itih1 | inter-alpha trypsin inhibitor, heavy chain 1 | 0.017 | ||
Apoa4 | apolipoprotein A-IV | 0.017 | Mouse | |
Rxra | retinoid X receptor alpha | 0.017 | ||
Fga | fibrinogen alpha chain | 0.017 | ||
Ghr | growth hormone receptor | 0.016 | ||
Cps1 | carbamoyl-phosphate synthetase 1 | 0.016 | ||
Tgfb1 | transforming growth factor, beta 1 | 0.016 | ||
C3 | complement component 3 | 0.016 | ||
Itih4 | inter alpha-trypsin inhibitor, heavy chain 4 | 0.016 | ||
Lpin1 | lipin 1 | 0.015 | ||
Mmp9 | matrix metallopeptidase 9 | 0.015 | ||
Azgp1 | alpha-2-glycoprotein 1, zinc | 0.015 | ||
Abhd5 | abhydrolase domain containing 5 | 0.014 | ||
Hamp | hepcidin antimicrobial peptide | 0.014 | ||
Soat2 | sterol O-acyltransferase 2 | 0.014 | ||
Cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 0.014 | ||
Prnp | prion protein | 0.014 | ||
Ces1c | carboxylesterase 1C | 0.013 | ||
Agxt | alanine-glyoxylate aminotransferase | 0.013 | ||
Cyp1a2 | cytochrome P450, family 1, subfamily a, polypeptide 2 | 0.013 | ||
Serpina10 | serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.013 | ||
Serpind1 | serine (or cysteine) peptidase inhibitor, clade D, member 1 | 0.013 | ||
Sstr3 | somatostatin receptor 3 | 0.013 | ||
Habp2 | hyaluronic acid binding protein 2 | 0.012 | ||
Hsd17b2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.012 | ||
Hpx | hemopexin | 0.012 | ||
Klf15 | Kruppel-like factor 15 | 0.011 | ||
H1foo | H1 histone family, member O, oocyte-specific | 0.011 | ||
Cdkn1a | cyclin-dependent kinase inhibitor 1A (P21) | 0.011 | ||
Apoc1 | apolipoprotein C-I | 0.011 | ||
Nos1 | nitric oxide synthase 1, neuronal | 0.011 | ||
Mosc1 | MOCO sulphurase C-terminal domain containing 1 | 0.011 | ||
C8g | complement component 8, gamma polypeptide | 0.011 | ||
Cdhr5 | cadherin-related family member 5 | 0.011 | ||
Cyp2c70 | cytochrome P450, family 2, subfamily c, polypeptide 70 | 0.010 | ||
Nr0b2 | nuclear receptor subfamily 0, group B, member 2 | 0.010 | ||
Lect2 | leukocyte cell-derived chemotaxin 2 | 0.010 |